Regulacje i polityka gospodarcza · 06/11/2009

Availability for Licensing of U.S. Provisional Patent Application for Enhanced Substrates for Botulinum Neurotoxin Protease Activity

The U.S. Government, represented by the Secretary of the Army, has made available the licensing of a U.S. Provisional Patent Application concerning enhanced substrates for the protease activity of serotype a Botulinum neurotoxin, with Serial No. 61/252,675 filed on October 18, 2009.